NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2024 Earnings Cal

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2024 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2024 Earnings Call Transcript

insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

France , United States , North Carolina , Paris , France General , American , Americans , Jonathan Javitt , Dennis Mcbride , Richard Narido , Matthew Duffy , Michael Manyak , Fondation Fondamental , Dan Javitt , Andrew Nierenberg , Stephen Willard , Tim Moore , Nephron Pharmaceuticals , Head Of Bipolar Research At Harvard Mass , Office Of Undersecretary Defense , Defense Advanced Research Projects Agency , Department Of Defense , Us Navy , Harvard University , Nasdaq , Nrx Pharmaceuticals , Lotus Pharmaceuticals , Nrx Pharmaceuticals Inc , Northwestern University , Head Of Urology At George Washington University , Columbia University , Glaxosmithkline , Call Transcript May , First Quarter , Conference Call , Chief Business , Chief Executive Officer , Chief Scientist , Chief Financial Officer , Hope Therapeutics , American Society , Clinical Psychopharmacology Meeting , Professor Andrew Nierenberg , Bipolar Research , Harvard Mass General , Special Forces , Chief Strategy Officer , Northwestern Institutional Review Board , Charles River Labs , Qualified Infectious Disease Product , Fast Track , Priority Review , Rich Narido , Professor Michael Manyak , George Washington University , Urology Advisory Board ,